sepsis/알부민

FIELD OF THE INVENTION This invention relates to treatment of patients suffering from sepsis. More particularly, it relates to treating defined, subpopulations of patients who suffer from this condition. BACKGROUND AND PRIOR ART It has been estimated that there are more than 18 million cases of

FIELD OF THE INVENTION The present invention is related to the field of treatment of sepsis, particularly to use of fusion protein Slit2D2-HSA for a medicament for prophylaxis and/or treatment of sepsis. BACKGROUND OF THE INVENTION Sepsis refers to systemic inflammatory response syndrome (SIRS)

FIELD OF THE INVENTION The present invention relates generally to a blood replacement product, and more particularly to the combination of Human serum albumin and an amino acid solution. BACKGROUND OF THE INVENTION Human Serum Albumin is a Human blood derived product that is used to treat

FIELD OF THE INVENTION The present invention related to devices and associated methods for plasma detoxification. Specifically, the present invention relates to an extracorporeal system that uses an adsorption column containing activated charcoal and ionic and non-ionic resins in combination with a

CROSS-REFERERNCE TO RELATED APPLICATIONS This application is the national stage of International Application No. PCT/AT/2011/00273, filed Jun. 22, 2011, and claim priority benefit of Austrian Patent Application No. A 1073/2010, filed Jun. 24, 2010. These applications are incorporated by reference